Madrigal Pharmaceuticals (LTS:0JXI) Price-to-Tangible-Book : 9.11 (As of May. 21, 2025)

View and export this data going back to 2018. Start your Free Trial

What is Madrigal Pharmaceuticals Price-to-Tangible-Book?

As of today (2025-05-21), Madrigal Pharmaceuticals's share price is $290.00. Madrigal Pharmaceuticals's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was $31.82. Hence, Madrigal Pharmaceuticals's Price to Tangible Book Ratio of today is 9.11.

The historical rank and industry rank for Madrigal Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

LTS:0JXI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.75 Med: 6.53 Max: 121.4
Current: 9.26

During the past 13 years, Madrigal Pharmaceuticals's highest Price to Tangible Book Ratio was 121.40. The lowest was 0.75. And the median was 6.53.

LTS:0JXI's Price-to-Tangible-Book is ranked worse than
84.65% of 1199 companies
in the Biotechnology industry
Industry Median: 2.66 vs LTS:0JXI: 9.26

A closely related ratio is called PB Ratio. As of today, Madrigal Pharmaceuticals's share price is $290.00. Madrigal Pharmaceuticals's Book Value per Sharefor the quarter that ended in Mar. 2025 was $32.03. Hence, Madrigal Pharmaceuticals's P/B Ratio of today is 9.05.

Madrigal Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Madrigal Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Madrigal Pharmaceuticals Price-to-Tangible-Book Chart

Madrigal Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Tangible-Book

Get a 7-Day Free Trial

7.63

7.49

27.42

11.34

9.24

Madrigal Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Tangible-Book	Get a 7-Day Free Trial															6.53	7.14	6.16	9.24	10.10

Competitive Comparison of Madrigal Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Madrigal Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Madrigal Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Madrigal Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Madrigal Pharmaceuticals's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

Madrigal Pharmaceuticals Price-to-Tangible-Book Calculation

Madrigal Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2025 )
	=	290.00	/	31.819
	=	9.11

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Madrigal Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Madrigal Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Madrigal Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Madrigal Pharmaceuticals Inc (LTS:0JXI) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

MDGL:USA YDO1:Germany YDO1:Germany

Address

200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428

Website

https://www.madrigalpharma.com

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Madrigal Pharmaceuticals Headlines

No Headlines